These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20644200)

  • 1. Improving glycemic control and cardiometabolic risk through integrated treatment plans.
    Lavernia F
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS13-9. PubMed ID: 20644200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks and benefits of attaining HbA(1c) goals: examining the evidence.
    Shubrook JH
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS7-12. PubMed ID: 20644204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increasing epidemiology of diabetes and review of current treatment algorithms.
    Freeman JS
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS2-6. PubMed ID: 20644201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes mellitus in children and youth.
    Ramkumar S; Tandon N
    Indian J Pediatr; 2013 Mar; 80 Suppl 1():S87-94. PubMed ID: 23430571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and treatment of prediabetes to prevent progression to type 2 diabetes.
    Fonseca VA
    Clin Cornerstone; 2008; 9(2):51-9; discussion 60-1. PubMed ID: 19410162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
    Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
    J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible severe deterioration of glycaemic control after withdrawal of metformin treatment.
    Panossian Z; Drury PL; Cundy T
    Diabetologia; 2012 Jan; 55(1):267-9. PubMed ID: 22072157
    [No Abstract]   [Full Text] [Related]  

  • 9. Options for intensifying diabetes treatment.
    Reid TS
    J Fam Pract; 2011 Sep; 60(9 Suppl):S7-10. PubMed ID: 21912777
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.
    Gavin JR; Stolar MW; Freeman JS; Spellman CW
    J Am Osteopath Assoc; 2010 May; 110(5 Suppl 6):S2-14; quiz S15-6. PubMed ID: 20554501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of glycemic control and β-cell function in new onset T2DM patients with PCOS of metformin and saxagliptin monotherapy or combination treatment.
    Tao T; Wu P; Wang Y; Liu W
    BMC Endocr Disord; 2018 Feb; 18(1):14. PubMed ID: 29482528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
    Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
    Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical practice in type 2 diabetes: After metformin and lifestyle, then what?
    Cobble ME; Peters AL
    J Fam Pract; 2009 Nov; 58(11 Suppl Clinical):S7-14. PubMed ID: 19891948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes type 2 in pediatrics: diagnosis and management].
    Girardin CM; Schwitzgebel VM
    Rev Med Suisse; 2007 Apr; 3(107):1001-5. PubMed ID: 17526374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan.
    Al-Eitan LN; Nassar AM; Saadeh NA; Almomani BA
    Can J Diabetes; 2016 Dec; 40(6):496-502. PubMed ID: 27212046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Screening and Prevention of Diabetes Mellitus.
    Martinez LC; Sherling D; Holley A
    Prim Care; 2019 Mar; 46(1):41-52. PubMed ID: 30704659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
    Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current approaches to controlling type 2 diabetes].
    Ametov AS; Karpova EV; Ivanova EV
    Ter Arkh; 2009; 81(10):20-7. PubMed ID: 19947436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: HbA1c has low accuracy for prediabetes; lifestyle programs and metformin reduce progression to T2DM.
    Maki DG
    Ann Intern Med; 2017 Apr; 166(8):JC41. PubMed ID: 28418543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.